| scholarly article | Q13442814 |
| P50 | author | Jérôme Leprince | Q38544634 |
| P2093 | author name string | Hubert Vaudry | |
| Marie-Christine Tonon | |||
| Jean Costentin | |||
| Jean-Claude do Rego | |||
| Marie-Hélène Orta | |||
| P2860 | cites work | Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of alpha-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro | Q28342997 |
| Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors | Q28568270 | ||
| Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes | Q28569568 | ||
| Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain | Q28581512 | ||
| The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents | Q32144736 | ||
| Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain | Q33254281 | ||
| Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat | Q33649740 | ||
| Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptors | Q36712118 | ||
| Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects | Q42245904 | ||
| The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment | Q42680854 | ||
| The triakontatetraneuropeptide TTN increases [CA2+]i in rat astrocytes through activation of peripheral-type benzodiazepine receptors | Q43680247 | ||
| Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist | Q43815466 | ||
| Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein | Q43987607 | ||
| Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide Y and corticotropin-releasing hormone mRNAs in rat hypothalamus | Q44282880 | ||
| In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain | Q44828694 | ||
| In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat. | Q46696588 | ||
| Allosteric Modulation of the GABA‐Induced Chloride Current in Frog Melanotrophsa | Q48282245 | ||
| The octadecaneuropeptide ODN inhibits apomorphine-induced yawning in rats | Q48362574 | ||
| Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain | Q48470280 | ||
| Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization | Q48663665 | ||
| The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors | Q48762716 | ||
| Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site | Q48916724 | ||
| Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. | Q51648004 | ||
| Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide | Q51854315 | ||
| The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes | Q60731220 | ||
| Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN | Q73500568 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 1641-1648 | |
| P577 | publication date | 2006-12-06 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake | |
| P478 | volume | 32 |
| Q37800570 | A legacy of discovery: From monoamines to GABA |
| Q37939316 | Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. |
| Q37851170 | Behavioral effect of neuropeptides related to feeding regulation in fish |
| Q88801814 | Brain Glucose-Sensing Mechanism and Energy Homeostasis |
| Q91811325 | Editorial: Neuroendocrine Control of Feeding Behavior |
| Q39424395 | Emerging Signaling Pathway in Arcuate Feeding-Related Neurons: Role of the Acbd7. |
| Q46306392 | Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival |
| Q33736741 | Glial Endozepines Inhibit Feeding-Related Autonomic Functions by Acting at the Brainstem Level. |
| Q101232839 | Glial endozepines and energy balance: Old peptides with new tricks |
| Q36635285 | Gliotransmission and brain glucose sensing: critical role of endozepines |
| Q58587902 | High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy |
| Q35079248 | Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study |
| Q48247082 | Investigations of octylglyceryl dextran-graft-poly(lactic acid) nanoparticles for peptide delivery to the brain. |
| Q36768027 | Involvement of the Acyl-CoA binding domain containing 7 in the control of food intake and energy expenditure in mice. |
| Q37617417 | Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina |
| Q97423574 | Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI) |
| Q47267653 | Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease |
| Q37511056 | Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides |
| Q46399968 | Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. |
| Q34702087 | Potential of olfactory ensheathing cells from different sources for spinal cord repair |
| Q46594255 | Protective effect of the octadecaneuropeptide on hydrogen peroxide-induced oxidative stress and cell death in cultured rat astrocytes |
| Q35882421 | Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity |
| Q35971853 | Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides |
| Q26828875 | Role of non-neuronal cells in body weight and appetite control |
| Q28070013 | The Neuroendocrine Regulation of Food Intake in Fish: A Review of Current Knowledge |
| Q43122422 | The anorexigenic action of the octadecaneuropeptide (ODN) in goldfish is mediated through the MC4R- and subsequently the CRH receptor-signaling pathways |
| Q38265497 | The contribution of hypothalamic macroglia to the regulation of energy homeostasis |
| Q35096798 | The effects of ghrelin on energy balance and psychomotor activity in a goldfish model: an overview |
| Q92783710 | The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system |
| Q46806237 | The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway |
| Q34395516 | The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism. |
| Q48289117 | The octadecaneuropeptide stimulates somatolactin release from cultured goldfish pituitary cells |
| Q41635046 | The stimulatory effect of the octadecaneuropeptide ODN on astroglial antioxidant enzyme systems is mediated through a GPCR. |
| Q37814088 | Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders |
Search more.